Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Change in Cash (2022 - 2025)

Historic Change in Cash for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to -$1.6 million.

  • Neuraxis' Change in Cash fell 710.97% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 92264.59%. This contributed to the annual value of $3.6 million for FY2024, which is 216596.47% up from last year.
  • According to the latest figures from Q3 2025, Neuraxis' Change in Cash is -$1.6 million, which was down 710.97% from $4.0 million recorded in Q2 2025.
  • In the past 5 years, Neuraxis' Change in Cash registered a high of $4.0 million during Q2 2025, and its lowest value of -$1.7 million during Q1 2025.
  • For the 4-year period, Neuraxis' Change in Cash averaged around $331035.6, with its median value being $3192.0 (2024).
  • In the last 5 years, Neuraxis' Change in Cash skyrocketed by 2806667.22% in 2024 and then tumbled by 5309185.46% in 2025.
  • Quarter analysis of 4 years shows Neuraxis' Change in Cash stood at $245879.0 in 2022, then plummeted by 377.65% to -$682689.0 in 2023, then surged by 603.3% to $3.4 million in 2024, then crashed by 146.9% to -$1.6 million in 2025.
  • Its Change in Cash stands at -$1.6 million for Q3 2025, versus $4.0 million for Q2 2025 and -$1.7 million for Q1 2025.